Final trial confirms efficacy of Sanofi's dengue vaccine

PARIS, Sept 3 (Reuters) - French drugmaker Sanofi, developing the first vaccine against dengue fever, said its product reduced disease cases by 60.8 percent in a large final clinical trial.